Home › Type 2 Diabetes › Virginia › Arlington
Type 2 Diabetes clinical trials in Arlington, VA
15 studies for Type 2 Diabetes are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Seven Corners Medical Center, Falls Church · 4 mi away
- Carient Heart and Vascular, Manassas · 22 mi away
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Carient Heart and Vascular LLC-Reston, Reston · 14 mi away
- Carient Heart & Vascular - Manassas, Manassas · 22 mi away
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Manassas · 22 mi away
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RecruitingPhase 3
- Research Site, Manassas · 22 mi away
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
RecruitingPhase 2
- Conquest Research - Arlington, Vienna · 9 mi away
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RecruitingPhase 3
- Manassas Clinical Research Center, Manassas · 22 mi away
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
RecruitingPhase 2
- Conquest Research, Vienna · 9 mi away
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RecruitingPhase 3
- Manassas Clinical Research Center Inc, Manassas · 22 mi away
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
RecruitingPhase 3
- Carient Heart and Vascular, Manassas · 22 mi away
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Arlington
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
RecruitingObservational study
- Research Site, Potomac · 11 mi away
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
RecruitingPhase 2
- Manassas Clinical Research Center, Manassas · 22 mi away
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
RecruitingPhase 3
- Research Site, Potomac · 11 mi away
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
RecruitingPhase 2
- Burke Internal Medicine and Research, Burke · 11 mi away
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
RecruitingPhase 2
- Burke Internal Medicine & Research, Burke · 11 mi away
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL24 studies
- Boston, MA20 studies
- Chicago, IL19 studies
- Dallas, TX19 studies
- Miami, FL19 studies
- Columbus, OH18 studies
- Las Vegas, NV18 studies
- Atlanta, GA17 studies
- San Diego, CA17 studies
- Los Angeles, CA16 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer104 studies
- Metastatic Cancer53 studies
- Colorectal Cancer52 studies
- Cancer (all types)48 studies
- Ovarian Cancer46 studies
- Breast Cancer46 studies
- Lung Cancer40 studies
- Endometrial Cancer39 studies
- Pancreatic Cancer34 studies
- Head and Neck Squamous Cell Carcinoma26 studies
- Small Cell Lung Cancer23 studies
- Melanoma20 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.